M. Salvadó

发表

Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#

P. Suñé, N. Reig, R. Rojas-García, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort

J. Gámez, J. Vidal-Taboada, F. Rudilla, 2022, Neurological Sciences.

Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.

R. Ferré, J. Girona, N. Plana, 2020, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia

R. Ferré, J. Girona, N. Plana, 2020, Clínica e Investigación en Arteriosclerosis (English Edition).

Influence of early neurological complications on clinical outcome following lung transplant

M. Nadal, J. Solé, J. Gámez, 2017, PloS one.

SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement

M. Reilly, H. Houlden, J. Gámez, 2016, neurogenetics.

PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis

J. Gámez, Cándida Salvans, M. Morales, 2014, Journal of Neurology.

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

An Atypical Presentation of Upper Motor Neuron Predominant Juvenile Amyotrophic Lateral Sclerosis Associated with TARDBP Gene: A Case Report and Review of the Literature

M. Codina-Solà, E. García-Arumí, J. Sotoca, 2022, Genes.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort

J. Gámez, Gisela Gili, M. Salvadó, 2016, Journal of the Neurological Sciences.

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

P. Suñé, J. Gámez, M. Deu, 2019, Therapeutic advances in neurological disorders.

Intravenous immunoglobulin as monotherapy for myasthenia gravis during pregnancy

J. Gámez, M. Casellas, S. Manrique, 2017, Journal of the Neurological Sciences.

New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies

J. Sotoca, M. Salvadó, D. Sánchez-Tejerina, 2022, Journal of clinical medicine.

Limb-girdle myopathy and mild intellectual disability: The expanding spectrum of TANGO2-related disease

M. Codina-Solà, E. García-Arumí, E. Martínez-Sáez, 2023, Neuromuscular Disorders.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

Chronic progressive external ophthalmoplegia plus syndrome due to homozygous missense variant in TOP3A gene

M. Codina-Solà, E. García-Arumí, E. Martínez-Sáez, 2022, Clinical genetics.

Absence of HINT1 mutations in a UK and Spanish cohort of patients with inherited neuropathies

M. Reilly, H. Houlden, R. Rojas-García, 2015, Journal of Neurology.

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

J. Sotoca, A. Palasí, M. Salvadó, 2023, Acta Neurologica Scandinavica.

Myoclonic epilepsy in Down syndrome and Alzheimer disease.

J. Álvarez-Sabín, M. Menéndez-González, J. Salas-Puig, 2017 .

CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

À. López-López, N. Mahy, J. Gámez, 2014, PloS one.

CX 3 CR 1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

À. López-López, N. Mahy, J. Gámez, 2014 .

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

Identification and characterization of the novel point mutation m.3634A>G in the mitochondrial MT-ND1 gene associated with LHON syndrome.

X. de la Cruz, E. García-Arumí, J. Gámez, 2017, Biochimica et biophysica acta. Molecular basis of disease.

Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications

J. Sotoca, M. Salvadó, D. Sánchez-Tejerina, 2023, Cells.

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

A. Chiò, J. Kinet, C. Estol, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Incomplete penetrance in the Spanish family with limb‐girdle muscular dystrophy type 1F

J. Gámez, M. Salvadó, M. Gratacós, 2016, Muscle & nerve.

KATP Channel Expression and Genetic Polymorphisms Associated with Progression and Survival in Amyotrophic Lateral Sclerosis

M. Pugliese, N. Mahy, J. Gámez, 2018, Molecular Neurobiology.

CHANNEL EXPRESSION AND GENETIC POLYMORPHISMS ASSOCIATED WITH PROGRESSION AND SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS

M. Pugliese, J. Gámez, J. Vidal-Taboada, 2018 .

UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort

À. López-López, N. Mahy, J. Gámez, 2015, Journal of Neurology.

Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.

J. Camacho, J. Gámez, V. Vargas, 2015, World journal of gastroenterology.

RFC1 repeat expansions and cerebellar ataxia, neuropathy and vestibular areflexia syndrome: Experience and perspectives from a neuromuscular disorders unit

E. Tizzano, J. Hernández-Vara, J. Sotoca, 2023, Journal of the Neurological Sciences.

Haplotype Analysis of the First A4V-SOD1 Spanish Family: Two Separate Founders or a Single Common Founder?

J. Gámez, J. Vidal-Taboada, M. Morales, 2019, Front. Genet..

KATP Channel Expression and Genetic Polymorphisms Associated with Progression and Survival in Amyotrophic Lateral Sclerosis

M. Pugliese, N. Mahy, J. Gámez, 2018, Molecular Neurobiology.

Lithium for treatment of amyotrophic lateral sclerosis: much ado about nothing.

A. Martinez de la Ossa, J. Gámez, M. Salvadó, 2016 .

Identification of two novel RRM2B variants associated with autosomal recessive progressive external ophthalmoplegia in a family with pseudodominant inheritance pattern

M. Codina-Solà, E. García-Arumí, E. Martínez-Sáez, 2023, Journal of Human Genetics.

HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort

J. Gámez, J. Vidal-Taboada, F. Rudilla, 2022, Neurological Sciences.

[Fungal urinary infection in renal transplant].

M. Mir, J. Aubía, J. Masramon, 1985, Revista clinica espanola.

Lithium for treatment of amyotrophic lateral sclerosis: much ado about nothing.

M. Salvadó, M. Salvado, A. D. L. Ossa, 2016, Neurologia.